| Indication of Trial/Studies |
Clinical Phase of Trial |
Role in Trial |
Year in which trial was conducted |
| DM with COPD/Asthma |
Phase III |
CO -I |
2006 |
| Type 2 DM |
Phase III |
CO -I |
2007 |
| Asthma |
Phase III |
PI |
2007 |
| COPD |
Phase III |
CO -I |
2007 |
| Acute ill medical patient |
Phase III |
PI |
2008 |
| LRTI |
Phase III |
PI |
2008 |
| Allergic Rhinitis |
Phase III |
PI |
2008 |
| COPD |
Phase IIb |
PI |
2008 |
| Allergic Rhinitis |
Phase III |
PI |
2008 |
| Sepsis with DIC |
Phase IIb |
PI |
2008-09 |
| Bronchial Asthma |
Phase IIa |
PI |
2009 |
| Bronchial Asthma |
Phase II |
CO -I |
2009 |
| Antibiotics in LRTI |
Phase III |
PI |
2009 |
| Asthma |
Phase III |
PI |
2009 |
| Bronchial Asthma |
Phase III |
PI |
2009 |
| COPD |
Phase III |
PI |
2009 |
| Influenza |
Phase III |
PI |
2011 |
| COPD |
Phase III |
PI |
2012 |
| Community Acquired bacterial pneumonia |
Phase III |
PI |
2012 |
| Fungal infection |
Phase III |
PI |
2012 |
| COPD |
Phase III |
PI |
2012 |
| COPD |
Phase III |
Co-PI |
2012 |
| COPD |
Phase III |
Co-PI |
2012 |
| Pediatric Bronchial Asthma |
Phase III |
PI |
2012 |
| Lower Respiratory Tract Infection |
Phase III |
PI |
2012-2014 |
| Asthma |
Phase III |
PI |
2013-2015 |
| COPD |
Phase III |
PI |
2014-2016 |
| Influenza |
Phase IIIb |
PI |
2022 |
| Eosinophilic Asthma |
Phase IV |
PI |
2022 |